Your Cart is Empty
Start shopping
CHA Meditech Co., Ltd., the Hyafilia manufacturer, is a South Korean bio-aesthetics company specializing in hyaluronic acid-based dermal fillers and other medical devices. Its Hyafilia range was developed to support aesthetic treatments such as wrinkle correction, facial volumization, and contouring through formulations designed for durability and tissue integration.
The company originated from the medical device development division of CHA Biotech and has continued to expand its work in biomaterials and aesthetic medicine. Its research and manufacturing efforts include the development of advanced filler technologies intended to balance cohesiveness, elasticity, and natural-looking results.
This article explores CHA Meditech’s history, research and development activities, manufacturing standards, and contributions to the aesthetic industry, along with the technologies behind its Hyafilia dermal fillers.
Key Takeaways
- CHA Meditech Co., Ltd., founded in 2013, is a South Korean leader in bioaesthetics. It specializes in hyaluronic acid-based dermal fillers and medical devices.
- The company’s flagship product, Hyafilia, features advanced V-Phasic Technology for durability and cohesiveness. It caters to various aesthetic concerns, including wrinkle reduction and facial contouring.
- CHA Meditech emphasizes safety and efficacy, adhering to international standards such as CE certification and ISO guidelines, with robust quality control at every production stage.
- Through its contributions to non-surgical aesthetics, CHA Meditech has set new benchmarks for quality, safety, and patient satisfaction.
About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and a range of medical and aesthetic products for your practice. We offer authentic products from leading brands at the lowest prices. Contact Doctor Medica today!
Recommended products
Introduction to CHA Meditech Co
CHA Meditech Co., Ltd. is a leading bio-aesthetics company based in South Korea. Founded in August 2013, it originated from the medical device development division of CHA Biotech, a subsidiary of the CHA Bio Group. The company specializes in developing and manufacturing advanced biomaterials, cosmetics, and medical devices, with a particular focus on hyaluronic acid-based dermal fillers.
CHA Meditech is dedicated to improving human lifestyles through cutting-edge bio-aesthetic innovations. Their mission is to create more beautiful lifestyles by leveraging their extensive research and development in biomaterials and medical devices. The company values quality, innovation, and global expansion, aiming to provide high-quality products to markets worldwide.[1]
Hyafilia Manufacturer Research and Development Processes
CHA Meditech Co., Ltd. is deeply committed to research and development, continuously striving to innovate in the field of dermal filler technology. Its state-of-the-art facilities support the company’s R&D efforts, including a 300L biopilot plant for biologics manufacturing. CHA Meditech collaborates with international researchers to develop advanced biomaterials, such as hyaluronic acid-based fillers, peptides, and growth factors.
Innovation is at the heart of CHA Meditech’s approach, with a focus on creating products that offer natural volume and elasticity. Their Hyafilia fillers, for example, feature V-Phasic Technology, which integrates bi-phasic and mono-phasic fillers for enhanced durability and cohesiveness.[2] This focus on formulation and manufacturing consistency is also relevant for clinics sourcing the product for professional use. Licensed practitioners who buy Hyafilia online should work with reputable medical suppliers that can verify product authenticity and appropriate storage and handling throughout the supply chain.
Quality control and testing are paramount at CHA Meditech. The company adheres to stringent Good Manufacturing Practices (GMP) certified by the Ministry of Food & Drug Safety (MFDS) of Korea and European ISO standards. Automated manufacturing facilities and exhaustive facility management ensure that every product meets the highest quality standards before reaching the market.
Safety and Efficacy of Hyafilia Dermal Fillers
Hyafilia dermal fillers are designed with a strong emphasis on safety and efficacy, adhering to international standards and guidelines. While Hyafilia vs Juvederm comparisons often highlight differences in market presence and regulatory status, Hyafilia maintains rigorous quality assurance through compliance with CE certification and other global benchmarks. These certifications ensure the fillers meet stringent safety and performance requirements.[3]
Clinical trials and studies further support Hyafilia’s efficacy, demonstrating its ability to effectively reduce wrinkles, restore volume, and enhance facial contours with long-lasting, natural-looking results. The formulation’s advanced crosslinking technology minimizes side effects while maximizing durability and integration into the skin.
CHA Meditech also conducts extensive testing at every production stage, ensuring consistency and reliability across its product line. This commitment to safety and innovation makes Hyafilia a trusted choice for patients seeking effective non-surgical aesthetic solutions.
Contributions to the Aesthetic Industry
As the Hyafilia manufacturer, CHA Meditech has contributed to the aesthetic industry through continued development of hyaluronic acid-based fillers designed for wrinkle correction, volume restoration, and facial contouring. Their commitment to research and development has led to the creation of reliable and cutting-edge products, helping to shape the future of non-surgical aesthetic treatments.
As a result, CHA Meditech has become a trusted name in the industry and is known for its dedication to quality and innovation.
Conclusion
CHA Meditech Co., Ltd. has established itself in the aesthetic industry through its focus on biomaterials, dermal filler technology, and manufacturing quality. As the Hyafilia manufacturer, the company continues to develop products intended to address a range of non-surgical aesthetic treatment needs.
CHA Meditech has become a trusted name in non-surgical aesthetic solutions by prioritizing quality and patient satisfaction, shaping the future of dermal fillers and non-invasive treatments.
FAQs
1. What is CHA Meditech Co., Ltd.?
CHA Meditech Co., Ltd. is a South Korean company that specializes in biomaterials, hyaluronic acid-based dermal fillers, and other medical devices. It focuses on non-surgical aesthetic treatments.
2. What are the common uses of Hyafilia fillers?
Hyafilia fillers are used for wrinkle reduction, facial volumization, contouring, and enhancing skin elasticity and hydration.
3. How does CHA Meditech contribute to the aesthetic industry?
CHA Meditech advances non-surgical aesthetics through innovative dermal filler technologies, stringent safety protocols, and a commitment to research and development.
Citations
[1] CHA Meditech Co., Ltd. “Company.” CHA Meditech.
[2] CHA Meditech Co., Ltd. “HYAFILIA (Dermal Filler).” CHA Meditech.
[3] Jang, Joon Chul, et al. “The Efficacy of New Hyaluronic Acid Filler (HyaFilia).” Journal of the Korean Society of Plastic and Reconstructive Surgeons, vol. 38, no. 1, 2011, pp. 1–6. Semantic Scholar.
The content on this page has been written and fact-checked in accordance with our Editorial Policy. Clinical claims are sourced from peer-reviewed literature, regulatory documentation, and manufacturer specifications. Where citations are provided, it is always in accordance to our editorial standards.